Inventor · disambiguated record
Souphalone Luangsay
Also filed as: LUANGSAY SOUPHALONE
5 granted patents·13 pending applications·8 citations·filing 2017–2024
73Inventor score
Files withHOFFMANN LA ROCHE15HOFFMANN LA ROCHE INC1LUANGSAY SOUPHALONE1ROCHE INNOVATION CT COPENHAGEN AS1
Top patents by PatentIndex Score
18 records- 0189US10829555B2Oligonucleotides for reduction of PD-L1 expressionHOFFMANN LA ROCHE·Filed 2020·Granted Nov 10, 2020·3 cites·14 claims
- 0287US10745480B2Oligonucleotides for reduction of PD-L1 expressionHOFFMANN LA ROCHE·Filed 2019·Granted Aug 18, 2020·3 cites·30 claims
- 0386US11466081B2Oligonucleotides for reduction of PD-L1 expressionHOFFMANN LA ROCHE·Filed 2020·Granted Oct 11, 2022·2 cites·22 claims
- 0470US2024182898A1ENHANCED OLIGONUCLEOTIDES FOR INHIBITING RTELl EXPRESSIONHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0568US11898145B2Enhanced oligonucleotides for inhibiting RTEL1 expressionHOFFMANN LA ROCHE·Filed 2022·Granted Feb 13, 2024·0 cites·17 claims
- 0667US2024150758A1Use of fubp1 inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 0765US2025263705A2Pharmaceutical combinations for treatment of hbvLUANGSAY SOUPHALONE·Filed 2024·Application pending·0 cites
- 0865US2024409939A1Combination of oligonucleotides for modulating rtel1 and fubp1HOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 0964US2023257748A1Use of a1cf inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2023·Application pending·0 cites
- 1059US11732262B2Use of FUBP1 inhibitors for treating hepatitis B virus infectionHOFFMANN—LA ROCHE INC·Filed 2020·Granted Aug 22, 2023·0 cites·10 claims
- 1156US2023118138A1Use of scamp3 inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1256US2023193263A1Use of sbds inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1356US2023122751A1Use of cops3 inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1456US2023183692A1Use of sept9 inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1555US2017283496A1Oligonucleotides for reduction of pd-l1 expressionROCHE INNOVATION CT COPENHAGEN AS·Filed 2017·Application pending·0 cites
- 1653US2024168015A1Method for the detection of organ derived extracellular vesiclesHOFFMANN LA ROCHE·Filed 2024·Application pending·0 cites
- 1751US2023120063A1Use of saraf inhibitors for treating hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2022·Application pending·0 cites
- 1849US2022031730A1Enhanced oligonucleotides for modulating fubp1 expressionHOFFMANN LA ROCHE·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Souphalone Luangsay files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →